Gagnon Robert E. 4
4 · Bone Biologics Corp · Filed Jun 6, 2025
Insider Transaction Report
Form 4
Gagnon Robert E.
Director
Transactions
- Award
Non-Employee Stock Option
2025-06-04+62,894→ 62,894 totalExercise: $0.88Exp: 2035-06-04→ Common Stock (62,894 underlying)
Holdings
- 8,006
Non-Employee Stock Option
Exercise: $4.68Exp: 2034-01-08→ Common Stock (8,006 underlying) - 30,713
Non-Employee Stock Option
Exercise: $1.73Exp: 2034-09-17→ Common Stock (30,713 underlying) - 9
Non-Employee Stock Option
Exercise: $4.68Exp: 2034-01-08→ Common Stock (9 underlying)
Footnotes (3)
- [F1]This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests in four equal quarterly installments.
- [F2]This option was granted on 9/17/2024 and vests in four equal quarterly installments.
- [F3]This option is fully exercisable as of the date of this report.